Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

On a per-share basis, the New York-based company said it had profit of 52 cents. Earnings, adjusted for amortization costs and restructuring costs, were 92 cents per share.

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Pfizer (NYSE:PFE – Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Tuesday, April 29th. Analysts expect Pfizer to post earnings of $0.67 ...

Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns after earnings releases.

Pfizer’s PFE 2024 revenue reached $63.6 billion, near the high end of its $61 billion-$64 billion guidance range. Management reaffirmed expectations for 2025 revenue of $61 billion-$64 billion ...

Pfizer (PFE) is set to announce Q3 earnings with analysts predicting strong profit and revenue growth.

Our interactive dashboard analysis of Pfizer’s FY 2024Q3 Earnings Preview has more details on the company’s revenues and earnings for the quarter.

Pfizer's Q3 consensus estimate is likely to be exceeded. Despite the underperformance over the past two months, see why PFE stock deserves "Buy" rating here.

Pfizer (PFE) will report Q3 2024 earnings on October 29, with expectations of $15.19 billion in sales and earnings of $0.64 per share. Pfizer has consistently beaten earnings estimates, with a ...